Lopes, Hugo http://orcid.org/0000-0002-5808-9154
Lopes, Andrea Rodrigues
Farinha, Helena http://orcid.org/0000-0003-3243-1617
Martins, Ana Paula http://orcid.org/0000-0002-3988-1162
Funding for this research was provided by:
Gilead Sciences (project number 2497421)
Novartis (project number 2720975)
Article History
Received: 5 January 2021
Accepted: 10 June 2021
First Online: 24 June 2021
Funding
: The literature review and the rounds with the experts had the financial support of Gilead Sciences (Project Number 2497421) and Novartis (Project Number 2720975). Nevertheless, this funding had no influence on the writing of the manuscript, which is the sole responsibility of the authors.
: HL and ARL are IQVIA employees, HF and APM are board members of the Portuguese Pharmaceutical Society.